Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($) $ in Thousands	Class A Common Stock	Additional Paid-in Capital.	Accumulated Other Comprehensive Loss	Accumulated Deficit.	Series A Preferred Stock	Total
Beginning balance, value at Dec. 31, 2020	$ 6	$ 86,768	$ 5,192	$ (47,498)		$ 44,468
Beginning balance, shares at Dec. 31, 2020	53,343,518				167,972
Conversion of accounts payable liabilities		1,626				1,626
Conversion of accounts payable liabilities (in shares)	793,375
Conversion of debt obligations		9,872				$ 9,872
Conversion of debt obligations (in shares)	3,935,472
Conversion of restricted shares (in shares)	543,642					543,642
Stock compensation		1,859				$ 1,859
Stock options exercised		247				$ 247
Stock options exercised (in shares)	322,434					322,434
Warrants exercised		50				$ 50
Warrants exercised	20,749
Shares issued for acquisition		404				404
Shares issued for acquisition (in shares)	142,882
Fixed dividends Preferred Series B		(634)				(634)
Deemed contribution from Series B preferred		367				367
Foreign currency translation			269			269
Net income (loss)				(7,388)		(7,388)
Ending balance, value at Jun. 30, 2021	$ 6	100,559	5,461	(54,886)		51,140
Ending balance, shares at Jun. 30, 2021	59,102,072				167,972
Beginning balance, value at Mar. 31, 2021	$ 6	95,084	4,931	(52,666)		47,355
Beginning balance, shares at Mar. 31, 2021	56,786,557				167,972
Conversion of debt obligations		3,839				$ 3,839
Conversion of debt obligations (in shares)	1,687,809
Conversion of restricted shares (in shares)	484,824					484,824
Stock compensation		1,182				$ 1,182
Stock options exercised (in shares)						0
Shares issued for acquisition		404				$ 404
Shares issued for acquisition (in shares)	142,882
Fixed dividends Preferred Series B		(317)				(317)
Deemed contribution from Series B preferred		367				367
Foreign currency translation			530			530
Net income (loss)				(2,220)		(2,220)
Ending balance, value at Jun. 30, 2021	$ 6	100,559	5,461	(54,886)		51,140
Ending balance, shares at Jun. 30, 2021	59,102,072				167,972
Beginning balance, value at Dec. 31, 2021	$ 6	110,867	3,728	(61,300)		$ 53,301
Beginning balance, shares at Dec. 31, 2021	63,821,901				167,972
Conversion of debt obligations (in shares)	528,169
Conversion of restricted shares	$ 1			(1)
Conversion of restricted shares (in shares)	1,660,806					1,660,806
Stock compensation		2,062				$ 2,062
Stock options exercised		58				$ 58
Stock options exercised (in shares)	196,841					196,841
Fixed dividends Preferred Series B		(635)				$ (635)
Foreign currency translation			(6,409)			(6,409)
Net income (loss)				(4,829)		(4,829)
Ending balance, value at Jun. 30, 2022	$ 7	112,352	(2,681)	(66,130)		43,548
Ending balance, shares at Jun. 30, 2022	66,207,717				167,972
Beginning balance, value at Mar. 31, 2022	$ 7	111,715	1,956	(66,156)		$ 47,522
Beginning balance, shares at Mar. 31, 2022	65,522,438				167,972
Conversion of restricted shares (in shares)	544,688					544,688
Stock compensation		929				$ 929
Stock options exercised		25				$ 25
Stock options exercised (in shares)	140,591					140,591
Fixed dividends Preferred Series B		(317)				$ (317)
Foreign currency translation			(4,637)			(4,637)
Net income (loss)				26		26
Ending balance, value at Jun. 30, 2022	$ 7	$ 112,352	$ (2,681)	$ (66,130)		$ 43,548
Ending balance, shares at Jun. 30, 2022	66,207,717				167,972